Variant report
Variant | nsv528332 |
---|---|
Chromosome Location | chr1:228016370-228019842 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1582114 | chr1:228016370-228016371 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138995958 | chr1:228016384-228016385 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35941477 | chr1:228016392-228016393 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576005890 | chr1:228016406-228016407 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191841755 | chr1:228016408-228016409 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs34102637 | chr1:228016458-228016459 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184061471 | chr1:228016459-228016460 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs398074710 | chr1:228016462-228016463 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs397983100 | chr1:228016463-228016464 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372518484 | chr1:228016464-228016465 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573852442 | chr1:228016501-228016502 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573270143 | chr1:228016537-228016538 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540693204 | chr1:228016566-228016567 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs140539856 | chr1:228016636-228016637 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529282037 | chr1:228016646-228016647 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544188774 | chr1:228016687-228016688 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1113474 | chr1:228016738-228016739 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs533020346 | chr1:228016803-228016804 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144384383 | chr1:228016824-228016825 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560269302 | chr1:228016825-228016826 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs28660431 | chr1:228016826-228016827 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
22 | rs187889028 | chr1:228016900-228016901 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567359407 | chr1:228016901-228016902 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553075180 | chr1:228016913-228016914 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs74982771 | chr1:228016919-228016920 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549749730 | chr1:228016972-228016973 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138951620 | chr1:228016975-228016976 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375798631 | chr1:228016978-228016979 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Autism | 14699429 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Fumarase deficiency | 21572526 | CNVD |
Autism | 17483303 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
Myelofibrosis | 22110671 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:228014800-228016800 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
2 | chr1:228015000-228016800 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
3 | chr1:228015800-228017000 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
4 | chr1:228016000-228017000 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
5 | chr1:228016200-228016600 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
6 | chr1:228016200-228017000 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr1:228016600-228016800 | Bivalent/Poised TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
8 | chr1:228016600-228017000 | Enhancers | Dnd41 | blood |
9 | chr1:228016600-228017000 | Enhancers | HMEC | breast |